We are live on
!
Find out more
CGL
Clarius Group LLC Portfolio holdings
AUM
$1.75B
1-Year Est. Return
19.04%
This Fund
S&P 500
This Quarter
Est. Return
+10.44%
1 Year Est. Return
+19.04%
3 Year Est. Return
+92.07%
5 Year Est. Return
+98.79%
10 Year Est. Return
+415.93%
AUM
$1.29B
AUM Growth
+$116M
(+9.9%)
Cap. Flow
+$6.02M
Cap. Flow
% of AUM
0.46%
Top 10 Holdings %
Top 10 Hldgs %
52.74%
Holding
529
New
19
Increased
248
Reduced
179
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Euclidean Fundamental Value ETF
ECML
|
+$13.2M |
| 2 |
Denali Therapeutics
DNLI
|
+$2.47M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.39M |
| 4 |
Broadcom
AVGO
|
+$1.06M |
| 5 |
Lyell Immunopharma
LYEL
|
+$1.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PACCAR
PCAR
|
+$4.8M |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$4.39M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$1.06M |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$904K |
| 5 |
iShares Intermediate Government/Credit Bond ETF
GVI
|
+$720K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.57% |
| 2 | Industrials | 17.79% |
| 3 | Consumer Discretionary | 8.08% |
| 4 | Healthcare | 7.99% |
| 5 | Financials | 5.18% |
Similar funds
A
CB
JCM
GH
MPM
NAS
RC
LGWM
Clarius Group LLC's Q2 2023 Portfolio in Review
As of Q2 2023, Clarius Group LLC held 529 positions worth $1.29B, up 9.9% from $1.18B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Clarius Group LLC's Q2 2023 filing shows 19 new, 248 increased, 179 reduced and 39 closed positions. Its largest new stake was Euclidean Fundamental Value ETF: 507,159 shares worth $14M. The largest sale was PACCAR, an estimated $4.8M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Clarius Group LLC's largest Q2 2023 buy was Euclidean Fundamental Value ETF: 507,159 shares worth $14M.
- Clarius Group LLC added most to Denali Therapeutics in Q2 2023, an estimated $2.47M increase.
- Clarius Group LLC's biggest Q2 2023 reduction was PACCAR, cutting an estimated $4.8M.
- Clarius Group LLC fully exited iShares National Muni Bond ETF in Q2 2023, selling an estimated $904K.
- Clarius Group LLC's ten largest holdings make up 53% of its $1.29B portfolio in Q2 2023.
- Clarius Group LLC opened 19 new positions and closed 39 in Q2 2023.
- Clarius Group LLC's portfolio value rose 9.9% quarter-over-quarter to $1.29B.
Based on Clarius Group LLC's 13F filing for Q2 2023, filed 10 Aug 2023.